Zhang B. Xu

913 total citations
7 papers, 789 citations indexed

About

Zhang B. Xu is a scholar working on Genetics, Organic Chemistry and Computational Theory and Mathematics. According to data from OpenAlex, Zhang B. Xu has authored 7 papers receiving a total of 789 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 3 papers in Organic Chemistry and 2 papers in Computational Theory and Mathematics. Recurrent topics in Zhang B. Xu's work include Estrogen and related hormone effects (7 papers), Synthesis and biological activity (3 papers) and Computational Drug Discovery Methods (2 papers). Zhang B. Xu is often cited by papers focused on Estrogen and related hormone effects (7 papers), Synthesis and biological activity (3 papers) and Computational Drug Discovery Methods (2 papers). Zhang B. Xu collaborates with scholars based in United States and Canada. Zhang B. Xu's co-authors include Eric S. Manas, Heather A. Harris, Rayomand J. Unwalla, W.S. Somers, Chris P. Miller, Ruth A. Henderson, Michael S. Malamas, James C. Keith, Robert McDevitt and Michael D. Collini and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Structure.

In The Last Decade

Zhang B. Xu

7 papers receiving 760 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhang B. Xu United States 7 455 309 231 175 96 7 789
Michael D. Collini Canada 8 261 0.6× 267 0.9× 194 0.8× 78 0.4× 55 0.6× 10 571
Ioanna Laı̈os Belgium 18 452 1.0× 180 0.6× 415 1.8× 93 0.5× 59 0.6× 28 873
Richard E. Mewshaw United States 20 329 0.7× 610 2.0× 421 1.8× 111 0.6× 59 0.6× 35 1.2k
Charles D. Jones United States 12 423 0.9× 364 1.2× 230 1.0× 66 0.4× 88 0.9× 14 861
J.C. Nwachukwu United States 20 420 0.9× 187 0.6× 550 2.4× 145 0.8× 55 0.6× 33 1.2k
Charles W. Lugar United States 11 234 0.5× 221 0.7× 175 0.8× 63 0.4× 59 0.6× 14 523
Iwan Gunawan United States 9 139 0.3× 234 0.8× 277 1.2× 167 1.0× 45 0.5× 11 653
René Maltais Canada 20 561 1.2× 316 1.0× 599 2.6× 87 0.5× 69 0.7× 84 1.1k
Martin Frotscher Germany 19 722 1.6× 359 1.2× 390 1.7× 76 0.4× 57 0.6× 46 1.2k
Germán A. Gil Argentina 15 303 0.7× 74 0.2× 498 2.2× 113 0.6× 35 0.4× 27 918

Countries citing papers authored by Zhang B. Xu

Since Specialization
Citations

This map shows the geographic impact of Zhang B. Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhang B. Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhang B. Xu more than expected).

Fields of papers citing papers by Zhang B. Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhang B. Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhang B. Xu. The network helps show where Zhang B. Xu may publish in the future.

Co-authorship network of co-authors of Zhang B. Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhang B. Xu. A scholar is included among the top collaborators of Zhang B. Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhang B. Xu. Zhang B. Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Mewshaw, Richard E., et al.. (2006). ERβ ligands. Part 5: Synthesis and structure–activity relationships of a series of 4′-hydroxyphenyl-aryl-carbaldehyde oxime derivatives. Bioorganic & Medicinal Chemistry Letters. 17(4). 902–906. 21 indexed citations
2.
Mewshaw, Richard E., Eric S. Manas, Zhang B. Xu, et al.. (2005). ERβ Ligands. 3. Exploiting Two Binding Orientations of the 2-Phenylnaphthalene Scaffold To Achieve ERβ Selectivity. Journal of Medicinal Chemistry. 48(12). 3953–3979. 128 indexed citations
3.
McDevitt, Robert, Michael S. Malamas, Eric S. Manas, et al.. (2005). Estrogen receptor ligands: design and synthesis of new 2-arylindene-1-ones. Bioorganic & Medicinal Chemistry Letters. 15(12). 3137–3142. 67 indexed citations
4.
Malamas, Michael S., Eric S. Manas, Robert McDevitt, et al.. (2004). Design and Synthesis of Aryl Diphenolic Azoles as Potent and Selective Estrogen Receptor-β Ligands. Journal of Medicinal Chemistry. 47(21). 5021–5040. 229 indexed citations
5.
Collini, Michael D., David H. Kaufman, Eric S. Manas, et al.. (2004). 7-Substituted 2-phenyl-benzofurans as ERβ selective ligands. Bioorganic & Medicinal Chemistry Letters. 14(19). 4925–4929. 36 indexed citations
6.
Manas, Eric S., Zhang B. Xu, Rayomand J. Unwalla, & W.S. Somers. (2004). Understanding the Selectivity of Genistein for Human Estrogen Receptor-β Using X-Ray Crystallography and Computational Methods. Structure. 12(12). 2197–2207. 156 indexed citations
7.
Manas, Eric S., Rayomand J. Unwalla, Zhang B. Xu, et al.. (2004). Structure-Based Design of Estrogen Receptor-β Selective Ligands. Journal of the American Chemical Society. 126(46). 15106–15119. 152 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026